Number of Founded Organizations 2
CB Rank (Person) 38,286
  • Primary Job Title Co-Founder, President, CEO
  • Primary Organization 
    Syntis Bio

Rahul Dhanda is co-founder, ceo and director of Syntis Bio. Previously, Rahul co-founded Sherlock Biosciences in early 2018, where he initially acquired exclusive rights to CRISPR and SynBio platforms for molecular diagnostics. As the founding CEO, President and Director, Rahul scaled the company by building a diverse and accomplished team to reach

commercialization of the first-ever CRISPR product, diagnostic or therapeutic, to be authorized by the FDA. He also directed the rapid advancement of the company’s SynBio platform towards the goal of being the first at-home, instrument-free molecular diagnostic. He secured over $55 million in capital, including $25 million in non-dilutive funding in the company’s Series A.

Under his leadership, Sherlock Biosciences has been named a Fast Company Most Innovative Company in 2021 (Top 10 in Biotech), a Red Herring Top 100 Company, Fierce15 MedTech, Tech Pioneer by the World Economic Forum, and Top 50 Innovative Company by BostonInno, among others. Rahul was named to Boston’s Power50 list by the Boston Business Journal in 2020.

As a strong advocate of equity in society and STEM, Rahul founded The 221b Foundation, a non-profit organization that provides access to CRISPR intellectual property for COVID-19 diagnostics, the profits of which are invested in STEM education initiatives promoting gender and racial diversity.

Prior to Sherlock Biosciences, Rahul helped build T2 Biosystems over ten years, resulting in a publicly-traded, commercial leader in infectious disease diagnostics. As Senior Vice President of Corporate Development and Marketing, he led multiple strategic and commercial initiatives including marketing, product management and all partnering activity, including over $40 million in deals. Prior to T2, Rahul worked at various diagnostic and medical device firms, including Boston Scientific where he managed over $100 million in product revenue.

Rahul earned his MBA from MIT’s Sloan School of Management and his B.A. from Wesleyan University. He is a former committee member of the AAAS Committee on Scientific Freedom and Responsibility. Mr. Dhanda is the author of several publications, an inventor on numerous patents, and has authored the first book to address the crossroads between industry and bioethics/public policy, entitled Guiding Icarus: Merging Bioethics with Corporate Interests.

Number of Current Jobs 1
Number of Past Jobs 4
Rahul Dhanda is the Co-Founder, President, CEO at Syntis Bio. Additionally, Rahul Dhanda has had 4 past jobs including CEO, President, Co-founder at Sherlock Biosciences.
Organization Name  
Title At Company  
Start Date  
End Date  
Sherlock Biosciences
CEO, President, Co-founderJan 1, 20182022
T2 Biosystems
Senior Vice President, Corp. Dev. and Marketing2008Mar 2018
Interleukin Genetics
Business Development
Boston Scientific
Marketing
There is no recent news or activity for this profile.